Misonidazole is a radiosensitizer that was investigated in clinical trials.
It was used in these trials for radiation therapy to cause normally resistant hypoxic tumor cells to become sensitive to the treatment.
[1][2]
This antineoplastic or immunomodulatory drug article is a stub.
You can help Wikipedia by expanding it.